top/bottom line beat fundament covid boost ep guid held
solid start compani saw revenu beat across board pbm benefit
covid stock up onboard ingeniorx sell season see strong retent retail also benefit
covid stock front back store though moder april pharmaci rx
rx sale front store custom switch rx day fill
custom traffic fallen post lockdown insur also benefit stronger govern enrol
partial off-set lower commerci gross margin in-lin beat lower
elect procedur defer care late march strong opex manag synergi allow om
beat lower interest expens help lower tax rate vs estim help manag
point net ep benefit covid stock-up lower health benefit claim quarter note
retail rx deliveri increas telemedicin minuteclin april
insur busi saw declin util across array healthcar servic look forward
ep guidanc remain unchang reduc capital-expenditure mm also remain commit
de-lever low see result good earli indic weather
covid storm well expect share react posit
posit pbm claim process mm vs evr mm
posit retail/ltc rx fill mm vs evr mm
neutral total medic membership mm vs evr mm
eps/ convers convers vs ep beat oper item
guidanc color expect impact covid outlook
expans profit healthhub initi upsid aetna caremark
profit cadenc potenti upsid aet integr
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
confer call et pw
valuat methodolog base mix discount cash flow analysi rel valuat multipl
potenti elev govern scrutini drug price transpar neg impact long-
potenti on-line competit amazon erod front end comp margin us
continu reimburs pressur us eu hit ultim lead total margin
articl articl
time dissemin may et
analyst elizabeth anderson amato michael newshel primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
report approv and/or distribut evercor group evercor group licens broker-deal regul
industri regulatori author finra evercor isi intern limit lsi uk authoris regul unit
kingdom financi conduct author institut sale trade research busi evercor group lsi uk collect
oper global market brand name evercor lsi evercor lsi evercor group lsi uk subsidiari evercor inc
evercor trademark logo servic mark shown report regist trademark evercor
analyst associ respons prepar report receiv compens base variou factor includ evercor partner
total revenu portion gener affili invest bank transact evercor lsi seek updat research
appropri variou regul may prevent happen certain instanc asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgment
evercor lsi gener prohibit analyst associ member household maintain financi interest secur
compani analyst area coverag except polici requir specif approv member complianc
depart ownership subject complianc applic regul disclosur evercor lsi also prohibit analyst associ
member household serv offic director advisori board member employe compani analyst
report may includ tactic call describ near-term event catalyst affect subject compani market overal
expect short-term price impact equiti share subject compani tactic call separ analyst
long-term recommend outperform under-perform reflect stock forward expect return formal rate
may differ target price recommend reflect analyst long-term view
applic current disclosur regard subject compani cover report avail offic evercor lsi
obtain write evercor group attn complianc fifth avenu floor new york ny
evercor affili respect director offic member employe may interest qualifi
hold issuer mention report evercor affili may busi relationship compani
mention report
addit inform secur financi instrument mention report avail upon request
evercor lsi recommend base stock total forecast return next month total forecast return equal
expect percentag price return plu gross dividend yield divid stock coverag three primari rate categori
outperform- total forecast return expect greater expect total return analyst coverag univers
line- total forecast return expect line expect total return analyst univers
underperform- total forecast return expect less expect total return analyst univers
coverag suspended- rate target price remov pursuant evercor lsi polici evercor act advisori
capac merger strateg transact involv compani certain circumst
rate suspended- evercor lsi suspend rate target price stock suffici fundament basi
determin legal regulatori polici constraint around publish rate target price previou rate target price
longer effect compani reli upon
prior octob coverag suspend rate suspend categori includ categori suspend
flnra requir member use rate system term buy hold/neutr sell equat
rate categori purpos evercor lsi rate distribut outperform
under-perform rate equat buy hold sell respect
prior march evercor lsi recommend base stock total forecast return next month
buy- total forecast return expect greater
hold- total forecast return expect greater equal less equal
sell -the total forecast return expect less
octob evercor acquir intern strategi invest group llc lsi group lsi uk acquisit
transfer evercor group research sale trade busi lsi group decemb combin research sale
trade busi transfer back evercor group intern reorgan sinc acquisit combin research sale
trade busi oper global market brand name evercor lsi
lsi group lsi uk
prior octob rate system lsi group lsi uk base risk adjust total return
buy- return
neutral return
cautious- return
disclosur purpos lsi group lsi uk rate view follow strong buy buy equat buy neutral equat hold
cautiou sell equat sell
prior octob rate system evercor group base stock expect total return rel analyst coverag
univers follow month stock coverag divid three categori
overweight- stock expect outperform averag total return analyst coverag univers next month
equal-weight- stock expect perform line averag total return analyst coverag univers next month
underweight -the stock expect under-perform averag total return analyst coverag univers next month
suspended- compani rate target price earn estim temporarili suspend
disclosur purpos evercor group prior overweight equal-weight underweight rate view buy hold
